Item 8.01 Other Events.

On April 12, 2023, Tenax Therapeutics, Inc. (the "Company") issued a press release providing a business update outlining the Company's product development plans for 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Attached hereto as Exhibit 99.2 and incorporated herein by reference is a corporate presentation that the Company plans to use with various investors and analysts.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description

  99.1          Press Release dated April 12, 2023.

  99.2          Corporate Presentation of April 2023.

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).





2

© Edgar Online, source Glimpses